{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T08:27:28Z","timestamp":1792744048071,"version":"4.5.0"},"reference-count":169,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T00:00:00Z","timestamp":1661126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Despite promising breakthroughs in diagnosing and treating acute coronary syndromes, cardiovascular disease\u2019s high global mortality rate remains indisputable. Nearly half of these patients died of ischemic heart disease. Primary percutaneous coronary intervention (PCI) and coronary artery bypass grafting can rapidly restore interrupted blood flow and become the most effective method for salvaging viable myocardium. However, restoring blood flow could increase the risk of other complications and myocardial cell death attributed to myocardial ischemia-reperfusion injury (IRI). How to reduce the damage of blood reperfusion to ischemic myocardium has become an urgent problem to be solved. In preclinical experiments, many treatments have substantial cardioprotective effects against myocardial IRI. However, the transition from these cardioprotective therapies to clinically beneficial therapies for patients with acute myocardial infarction remains elusive. The reasons for the failure of the clinical translation may be multi-faceted, and three points are summarized here: (1) Our understanding of the complex pathophysiological mechanisms of myocardial IRI is far from enough, and the classification of specific therapeutic targets is not rigorous, and not clear enough; (2) Most of the clinical patients have comorbidities, and single cardioprotective strategies including ischemia regulation strategies cannot exert their due cardioprotective effects under conditions of hyperglycemia, hypertension, hyperlipidemia, and aging; (3) Most preclinical experimental results are based on adult, healthy animal models. However, most clinical patients had comorbidities and received multiple drug treatments before reperfusion therapy. In 2019, COST Action proposed a multi-target drug combination initiative for prospective myocardial IRI; the optimal cardioprotective strategy may be a combination of additive or synergistic multi-target therapy, which we support. By establishing more reasonable preclinical models, screening multi-target drug combinations more in line with clinical practice will benefit the translation of clinical treatment strategies.<\/jats:p>","DOI":"10.3389\/fcvm.2022.967115","type":"journal-article","created":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T05:43:07Z","timestamp":1661146987000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":37,"title":["Preclinical multi-target strategies for myocardial ischemia-reperfusion injury"],"prefix":"10.3389","volume":"9","author":[{"given":"Yuqing","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3393","DOI":"10.1093\/eurheartj\/ehy253","article-title":"Cardioprotection research must leave its comfort zone.","volume":"39","author":"Heusch","year":"2018","journal-title":"Eur Heart J."},{"key":"B2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/nrcardio.2016.5","article-title":"Ischaemic conditioning and reperfusion injury.","volume":"13","author":"Hausenloy","year":"2016","journal-title":"Nat Rev Cardiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jacc.2018.09.086","article-title":"Multitarget strategies to reduce myocardial ischemia\/reperfusion injury: JACC review topic of the week.","volume":"73","author":"Davidson","year":"2019","journal-title":"J Am Coll Cardiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1093\/eurheartj\/ehw224","article-title":"The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge.","volume":"38","author":"Heusch","year":"2017","journal-title":"Eur Heart J."},{"key":"B5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00395-021-00874-8","article-title":"CAESAR\u2019s legacy: a new era of rigor in preclinical studies of cardioprotection.","volume":"116","author":"Bolli","year":"2021","journal-title":"Basic Res Cardiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1161\/CIRCRESAHA.117.310820","article-title":"Critical issues for the translation of cardioprotection.","volume":"120","author":"Heusch","year":"2017","journal-title":"Circ Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1161\/CIRCRESAHA.116.308736","article-title":"Time to give up on cardioprotection? A critical appraisal of clinical studies on ischemic pre-, post-, and remote conditioning.","volume":"119","author":"Heusch","year":"2016","journal-title":"Circ Res."},{"key":"B8","first-page":"68","article-title":"Myocardial necrosis induced by temporary occlusion of a coronary artery in the dog.","volume":"70","author":"Jennings","year":"1960","journal-title":"Arch Pathol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1136\/heartjnl-2014-306531","article-title":"Ischaemic conditioning: are we there yet?","volume":"101","author":"Bulluck","year":"2015","journal-title":"Heart."},{"key":"B10","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1161\/CIRCRESAHA.116.305348","article-title":"Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning.","volume":"116","author":"Heusch","year":"2015","journal-title":"Circ Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1093\/cvr\/cvs088","article-title":"Endogenous cardioprotection by ischaemic postconditioning and remote conditioning.","volume":"94","author":"Shi","year":"2012","journal-title":"Cardiovasc Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1258\/jrsm.2012.120049","article-title":"A systematic review and meta-analysis of the cardioprotective effects of remote ischaemic preconditioning in open cardiac surgery.","volume":"105","author":"Pilcher","year":"2012","journal-title":"J R Soc Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"S53","DOI":"10.1161\/CIRCULATIONAHA.109.926667","article-title":"Remote ischemic preconditioning in human coronary artery bypass surgery: from promise to disappointment?","volume":"122","author":"Rahman","year":"2010","journal-title":"Circulation."},{"key":"B14","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00424-016-1922-6","article-title":"Cardioprotection by remote ischemic conditioning and its signal transduction.","volume":"469","author":"Kleinbongard","year":"2017","journal-title":"Pflugers Arch."},{"key":"B15","doi-asserted-by":"publisher","first-page":"10742484221097273","DOI":"10.1177\/10742484221097273","article-title":"Bioassays of humoral cardioprotective factors released by remote ischemic conditioning in patients undergoing coronary artery bypass surgery.","volume":"27","author":"Lieder","year":"2022","journal-title":"J Cardiovasc Pharmacol Ther."},{"key":"B16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s00395-021-00856-w","article-title":"Cardioprotection by remote ischemic conditioning is transferable by plasma and mediated by extracellular vesicles.","volume":"116","author":"Lassen","year":"2021","journal-title":"Basic Res Cardiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1113\/expphysiol.2012.066217","article-title":"Role of the parasympathetic nervous system in cardioprotection by remote hindlimb ischaemic preconditioning.","volume":"98","author":"Donato","year":"2013","journal-title":"Exp Physiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1093\/cvr\/cvs212","article-title":"Cardioprotection evoked by remote ischaemic preconditioning is critically dependent on the activity of vagal pre-ganglionic neurones.","volume":"95","author":"Mastitskaya","year":"2012","journal-title":"Cardiovasc Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41569-020-0403-y","article-title":"Myocardial ischaemia-reperfusion injury and cardioprotection in perspective.","volume":"17","author":"Heusch","year":"2020","journal-title":"Nat Rev Cardiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00395-020-00825-9","article-title":"Targeting myocardial ischaemic injury in the absence of reperfusion.","volume":"115","author":"Basalay","year":"2020","journal-title":"Basic Res Cardiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1093\/cvr\/cvz053","article-title":"Cardiac innervation in acute myocardial ischaemia\/reperfusion injury and cardioprotection.","volume":"115","author":"Hausenloy","year":"2019","journal-title":"Cardiovasc Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.3390\/ijms20061449","article-title":"Use of multifactorial treatments to address the challenge of translating experimental myocardial infarct reduction strategies.","volume":"20","author":"Horton","year":"2019","journal-title":"Int J Mol Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.tcm.2019.10.011","article-title":"Hype or hope: vagus nerve stimulation against acute myocardial ischemia-reperfusion injury.","volume":"30","author":"Chen","year":"2020","journal-title":"Trends Cardiovasc Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/j.jcin.2017.05.063","article-title":"Vagal cardioprotection in reperfused acute myocardial infarction.","volume":"10","author":"Heusch","year":"2017","journal-title":"JACC Cardiovasc Interv."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e010326","DOI":"10.1161\/CIRCINTERVENTIONS.120.010326","article-title":"Hypothermia for reduction of myocardial reperfusion injury in acute myocardial infarction: closing the translational gap.","volume":"14","author":"El Farissi","year":"2021","journal-title":"Circ Cardiovasc Interv."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e560","DOI":"10.1097\/CCM.0000000000001297","article-title":"Effects of oxygen concentrations on postresuscitation myocardial oxidative stress and myocardial function in a rat model of cardiopulmonary resuscitation.","volume":"43","author":"Zhao","year":"2015","journal-title":"Crit Care Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.ahj.2014.01.015","article-title":"Clinical perspectives on reperfusion injury in acute myocardial infarction.","volume":"167","author":"Bainey","year":"2014","journal-title":"Am Heart J."},{"key":"B28","doi-asserted-by":"publisher","first-page":"4425","DOI":"10.1093\/eurheartj\/ehaa733","article-title":"Metoprolol exerts a non-class effect against ischaemia-reperfusion injury by abrogating exacerbated inflammation.","volume":"41","author":"Clemente-Moragon","year":"2020","journal-title":"Eur Heart J."},{"key":"B29","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s00395-020-0814-2","article-title":"Cardioprotection by early metoprolol- attenuation of ischemic vs. reperfusion injury?","volume":"115","author":"Kleinbongard","year":"2020","journal-title":"Basic Res Cardiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00395-020-0812-4","article-title":"Metoprolol blunts the time-dependent progression of infarct size.","volume":"115","author":"Lobo-Gonzalez","year":"2020","journal-title":"Basic Res Cardiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.trsl.2020.10.002","article-title":"Biphasic effect of metformin on human cardiac energetics.","volume":"229","author":"Emelyanova","year":"2021","journal-title":"Transl Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"107819","DOI":"10.1016\/j.pharmthera.2021.107819","article-title":"Nitrite and myocardial ischaemia reperfusion injury. Where are we now?","volume":"223","author":"Griffiths","year":"2021","journal-title":"Pharmacol Ther."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s00395-017-0662-x","article-title":"The RISK pathway and beyond.","volume":"113","author":"Rossello","year":"2018","journal-title":"Basic Res Cardiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s00018-020-03587-8","article-title":"Targeting the pathways of regulated necrosis: a potential strategy for alleviation of cardio-cerebrovascular injury.","volume":"78","author":"Lu","year":"2021","journal-title":"Cell Mol Life Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1111\/jcmm.14953","article-title":"Translational issues for mitoprotective agents as adjunct to reperfusion therapy in patients with ST-segment elevation myocardial infarction.","volume":"24","author":"B\u00f8tker","year":"2020","journal-title":"J Cell Mol Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jconrel.2020.11.054","article-title":"Pharmaceutical strategies for endoplasmic reticulum-targeting and their prospects of application.","volume":"329","author":"Shi","year":"2021","journal-title":"J Control Release."},{"key":"B37","doi-asserted-by":"publisher","first-page":"102884","DOI":"10.1016\/j.ebiom.2020.102884","article-title":"Mitochondria in acute myocardial infarction and cardioprotection.","volume":"57","author":"Ramachandra","year":"2020","journal-title":"EBioMedicine."},{"key":"B38","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41392-020-00455-6","article-title":"A double-edged sword of immuno-microenvironment in cardiac homeostasis and injury repair.","volume":"6","author":"Sun","year":"2021","journal-title":"Signal Transduct Target Ther."},{"key":"B39","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.molmed.2020.10.002","article-title":"Intercellular communication in the heart: therapeutic opportunities for cardiac ischemia.","volume":"27","author":"Martins-Marques","year":"2021","journal-title":"Trends Mol Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00395-021-00876-6","article-title":"The platelet paradox of injury versus protection in myocardial infarction-has it been overlooked?","volume":"116","author":"Kleinbongard","year":"2021","journal-title":"Basic Res Cardiol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1093\/cvr\/cvy286","article-title":"The coronary circulation in acute myocardial ischaemia\/reperfusion injury: a target for cardioprotection.","volume":"115","author":"Hausenloy","year":"2019","journal-title":"Cardiovasc Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1093\/cvr\/cvy314","article-title":"Circulating blood cells and extracellular vesicles in acute cardioprotection.","volume":"115","author":"Davidson","year":"2019","journal-title":"Cardiovasc Res."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-022-07345-9","article-title":"Platelet-mediated transfer of cardioprotection by remote ischemic conditioning and its abrogation by aspirin but not by Ticagrelor.","author":"Raphael Lieder","year":"2022","journal-title":"Cardiovasc Drugs Ther."},{"key":"B44","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.jacc.2018.05.052","article-title":"erythrocytes from patients with type 2 diabetes induce endothelial dysfunction via arginase I.","volume":"72","author":"Zhou","year":"2018","journal-title":"J Am Coll Cardiol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1161\/CIRCRESAHA.119.315344","article-title":"Optimized treatment of ST-elevation myocardial infarction.","volume":"125","author":"Niccoli","year":"2019","journal-title":"Circ Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00395-019-0756-8","article-title":"Coronary microvascular obstruction: the new frontier in cardioprotection.","volume":"114","author":"Heusch","year":"2019","journal-title":"Basic Res Cardiol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1161\/CIRCRESAHA.116.308640","article-title":"The coronary circulation as a target of cardioprotection.","volume":"118","author":"Heusch","year":"2016","journal-title":"Circ Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41569-021-00632-2","article-title":"A fresh look at coronary microembolization.","volume":"19","author":"Kleinbongard","year":"2022","journal-title":"Nat Rev Cardiol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"e29280","DOI":"10.7554\/eLife.29280","article-title":"Capillary pericytes mediate coronary no-reflow after myocardial ischaemia.","volume":"6","author":"O\u2019Farrell","year":"2017","journal-title":"Elife."},{"key":"B50","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1001\/jama.2022.0358","article-title":"Diagnosis and treatment of acute coronary syndromes: a review.","volume":"327","author":"Bhatt","year":"2022","journal-title":"JAMA."},{"key":"B51","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1161\/CIRCRESAHA.113.300987","article-title":"Historical perspective on the pathology of myocardial ischemia\/reperfusion injury.","volume":"113","author":"Jennings","year":"2013","journal-title":"Circ Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jacc.2021.10.034","article-title":"Intramyocardial hemorrhage and the \u201cwave front\u201d of reperfusion injury compromising myocardial salvage.","volume":"79","author":"Liu","year":"2022","journal-title":"J Am Coll Cardiol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1161\/hh2401.101385","article-title":"Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling.","volume":"89","author":"Jonassen","year":"2001","journal-title":"Circ Res."},{"key":"B54","doi-asserted-by":"publisher","first-page":"e010459","DOI":"10.1161\/CIRCINTERVENTIONS.121.010459","article-title":"Time to reperfusion in ST-Segment elevation acute myocardial infarction: when does the clock start?","volume":"14","author":"Murugiah","year":"2021","journal-title":"Circ Cardiovasc Interv."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1016\/j.jacc.2021.02.041","article-title":"Long-Term outcomes of patients with late presentation of ST-segment elevation myocardial infarction.","volume":"77","author":"Cho","year":"2021","journal-title":"J Am Coll Cardiol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1172\/JCI112160","article-title":"Myocardial reperfusion: a double-edged sword?","volume":"76","author":"Braunwald","year":"1985","journal-title":"J Clin Invest."},{"key":"B57","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/s41569-021-00506-7","article-title":"Myocardial stunning and hibernation revisited.","volume":"18","author":"Heusch","year":"2021","journal-title":"Nat Rev Cardiol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00395-020-0794-2","article-title":"A future for remote ischaemic conditioning in high-risk patients.","volume":"115","author":"Hausenloy","year":"2020","journal-title":"Basic Res Cardiol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1213\/ANE.0000000000005234","article-title":"Perioperative cardioprotection: clinical implications.","volume":"131","author":"Roth","year":"2020","journal-title":"Anesthes Analg."},{"key":"B60","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1161\/CIRCULATIONAHA.119.044176","article-title":"Is cardioprotection salvageable?","volume":"141","author":"Heusch","year":"2020","journal-title":"Circulation."},{"key":"B61","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41420-022-01031-3","article-title":"Targeting NAD+: is it a common strategy to delay heart aging?","volume":"8","author":"Yuan","year":"2022","journal-title":"Cell Death Discov."},{"key":"B62","doi-asserted-by":"publisher","first-page":"872","DOI":"10.3389\/fphar.2020.00872","article-title":"Targeting calcium homeostasis in myocardial ischemia\/reperfusion injury: an overview of regulatory mechanisms and therapeutic reagents.","volume":"11","author":"Wang","year":"2020","journal-title":"Front Pharmacol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1016\/j.jacc.2015.02.032","article-title":"Evolving therapies for myocardial ischemia\/reperfusion injury.","volume":"65","author":"Ib\u00e1\u00f1ez","year":"2015","journal-title":"J Am Coll Cardiol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1016\/j.apsb.2020.03.004","article-title":"Mitochondrial quality control mechanisms as molecular targets in cardiac ischemia-reperfusion injury.","volume":"10","author":"Wang","year":"2020","journal-title":"Acta Pharm Sin B."},{"key":"B65","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.phrs.2018.11.017","article-title":"How Ca(V)1.2-bound verapamil blocks Ca(2+) influx into cardiomyocyte: atomic level views.","volume":"139","author":"Li","year":"2019","journal-title":"Pharmacol Res."},{"key":"B66","doi-asserted-by":"publisher","first-page":"5529810","DOI":"10.1155\/2021\/5529810","article-title":"Novel insight into the role of endoplasmic reticulum stress in the pathogenesis of myocardial ischemia-reperfusion injury.","volume":"2021","author":"Zhu","year":"2021","journal-title":"Oxid Med Cell Longev"},{"key":"B67","doi-asserted-by":"publisher","first-page":"105743","DOI":"10.1016\/j.phrs.2021.105743","article-title":"Role of epigenetic regulation in myocardial ischemia\/reperfusion injury.","volume":"170","author":"Wang","year":"2021","journal-title":"Pharmacol Res."},{"key":"B68","doi-asserted-by":"publisher","first-page":"S1050","DOI":"10.1016\/j.tcm.2022.02.005","article-title":"Myocardial ischemia-reperfusion injury and the influence of inflammation.","volume":"22","author":"Algoet","year":"2022","journal-title":"Trends Cardiovasc Med."},{"key":"B69","doi-asserted-by":"publisher","first-page":"H891","DOI":"10.1152\/ajpheart.00259.2019","article-title":"Guidelines for evaluating myocardial cell death.","volume":"317","author":"Mishra","year":"2019","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1002\/cphy.c150006","article-title":"Pathophysiology of myocardial infarction.","volume":"5","author":"Frangogiannis","year":"2015","journal-title":"Compr Physiol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1172\/JCI62874","article-title":"Myocardial ischemia-reperfusion injury: a neglected therapeutic target.","volume":"123","author":"Hausenloy","year":"2013","journal-title":"J Clin Invest."},{"key":"B72","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1177\/1074248411409581","article-title":"Cell death pathways in acute ischemia\/reperfusion injury.","volume":"16","author":"Gottlieb","year":"2011","journal-title":"J Cardiovasc Pharmacol Ther."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1152\/physrev.00022.2018","article-title":"Fundamental mechanisms of regulated cell death and implications for heart disease.","volume":"99","author":"Del Re","year":"2019","journal-title":"Physiol Rev."},{"key":"B74","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1016\/j.jacc.2018.09.042","article-title":"Coronary microvascular disease pathogenic mechanisms and therapeutic options: JACC state-of-the-art review.","volume":"72","author":"Taqueti","year":"2018","journal-title":"J Am Coll Cardiol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"H550","DOI":"10.1152\/ajpheart.00183.2018","article-title":"No-reflow phenomenon in the heart and brain.","volume":"315","author":"Kloner","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1093\/cvr\/cvz301","article-title":"Pathophysiology and diagnosis of coronary microvascular dysfunction in ST-elevation myocardial infarction.","volume":"116","author":"Konijnenberg","year":"2020","journal-title":"Cardiovasc Res."},{"key":"B77","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1016\/j.jacc.2009.08.024","article-title":"Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with ST-segment elevation myocardial infarction: insight from cardiovascular magnetic resonance.","volume":"54","author":"Francone","year":"2009","journal-title":"J Am Coll Cardiol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"106995","DOI":"10.1016\/j.vph.2022.106995","article-title":"Challenges facing the clinical translation of cardioprotection: 35 years after the discovery of ischemic preconditioning.","volume":"144","author":"Penna","year":"2022","journal-title":"Vasc Pharmacol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"5252","DOI":"10.1111\/bph.14839","article-title":"Co-morbidities and co-medications as confounders of cardioprotection-Does it matter in the clinical setting?","volume":"177","author":"Kleinbongard","year":"2020","journal-title":"Br J Pharmacol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1124\/pr.113.008300","article-title":"Interaction of risk factors, comorbidities, and comedications with ischemia\/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning.","volume":"66","author":"Ferdinandy","year":"2014","journal-title":"Pharmacol Rev."},{"key":"B81","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s00395-021-00893-5","article-title":"Improving preclinical assessment of cardioprotective therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST action.","volume":"116","author":"Lecour","year":"2021","journal-title":"Basic Res Cardiol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"5312","DOI":"10.1111\/bph.14993","article-title":"Effect of hyperglycaemia and diabetes on acute myocardial ischaemia-reperfusion injury and cardioprotection by ischaemic conditioning protocols.","volume":"177","author":"Penna","year":"2020","journal-title":"Br J Pharmacol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.3390\/ijms21082896","article-title":"Diabetic cardiomyopathy and ischemic heart disease: prevention and therapy by exercise and conditioning.","volume":"21","author":"Crisafulli","year":"2020","journal-title":"Int J Mol Sci."},{"key":"B84","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.yjmcc.2015.12.020","article-title":"Ischemia reperfusion injury, ischemic conditioning and diabetes mellitus.","volume":"91","author":"Lejay","year":"2016","journal-title":"J Mol Cell Cardiol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"8880","DOI":"10.3390\/ijms22168880","article-title":"Influence of hyperglycemia and diabetes on cardioprotection by humoral factors released after remote ischemic preconditioning (RIPC).","volume":"22","author":"Torregroza","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B86","doi-asserted-by":"publisher","first-page":"101338","DOI":"10.1016\/j.arr.2021.101338","article-title":"Autophagy in the diabetic heart: a potential pharmacotherapeutic target in diabetic cardiomyopathy.","volume":"68","author":"Dewanjee","year":"2021","journal-title":"Ageing Res Rev."},{"key":"B87","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41401-018-0066-y","article-title":"Sevoflurane postconditioning protects against myocardial ischemia\/reperfusion injury by restoring autophagic flux via an NO-dependent mechanism.","volume":"40","author":"Qiao","year":"2019","journal-title":"Acta Pharmacol Sin."},{"key":"B88","doi-asserted-by":"publisher","first-page":"6657529","DOI":"10.1155\/2021\/6657529","article-title":"Inactivation of TOPK Caused by Hyperglycemia Blocks Diabetic Heart Sensitivity to Sevoflurane Postconditioning by Impairing the PTEN\/PI3K\/Akt Signaling.","volume":"2021","author":"Gao","year":"2021","journal-title":"Oxid Med Cell Longev."},{"key":"B89","doi-asserted-by":"publisher","first-page":"e96567","DOI":"10.1371\/journal.pone.0096567","article-title":"No evidence for activated autophagy in left ventricular myocardium at early reperfusion with protection by remote ischemic preconditioning in patients undergoing coronary artery bypass grafting.","volume":"9","author":"Gedik","year":"2014","journal-title":"PLoS One."},{"key":"B90","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s13105-021-00824-x","article-title":"The potentials of distinct functions of autophagy to be targeted for attenuation of myocardial ischemia\/reperfusion injury in preclinical studies: an up-to-date review.","volume":"77","author":"Mokhtari","year":"2021","journal-title":"J Physiol Biochem."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1007\/s11033-021-06987-6","article-title":"Alpha-lipoic acid preconditioning plus ischemic postconditioning provides additional protection against myocardial reperfusion injury of diabetic rats: modulation of autophagy and mitochondrial function.","volume":"49","author":"Mokhtari","year":"2022","journal-title":"Mol Biol Rep."},{"key":"B92","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1475-2840-11-67","article-title":"Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning.","volume":"11","author":"Miki","year":"2012","journal-title":"Cardiovasc Diabetol."},{"key":"B93","first-page":"892","article-title":"Cardioprotective effects of co-administration of thymoquinone and ischemic postconditioning in diabetic rats.","volume":"24","author":"Ran","year":"2021","journal-title":"Iran J Basic Med Sci."},{"key":"B94","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s13105-016-0530-4","article-title":"Chronic type-I diabetes could not impede the anti-inflammatory and anti-apoptotic effects of combined postconditioning with ischemia and cyclosporine A in myocardial reperfusion injury.","volume":"73","author":"Badalzadeh","year":"2017","journal-title":"J Physiol Biochem."},{"key":"B95","doi-asserted-by":"publisher","first-page":"5052","DOI":"10.1002\/jcp.30214","article-title":"Hydrogen sulfide restores sevoflurane postconditioning mediated cardioprotection in diabetic rats: role of SIRT1\/Nrf2 signaling-modulated mitochondrial dysfunction and oxidative stress.","volume":"236","author":"Zhang","year":"2021","journal-title":"J Cell Physiol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"9213034","DOI":"10.1155\/2016\/9213034","article-title":"N-Acetylcysteine restores sevoflurane postconditioning cardioprotection against myocardial ischemia-reperfusion injury in diabetic rats.","volume":"2016","author":"Lin","year":"2016","journal-title":"J Diabetes Res."},{"key":"B97","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3389\/fphar.2020.00006","article-title":"Deferoxamine Treatment combined with sevoflurane postconditioning attenuates myocardial ischemia-reperfusion injury by restoring HIF-1\/BNIP3-mediated mitochondrial autophagy in GK rats.","volume":"11","author":"Yang","year":"2020","journal-title":"Front Pharmacol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/apha.12874","article-title":"Deferoxamine-activated hypoxia-inducible factor-1 restores cardioprotective effects of sevoflurane postconditioning in diabetic rats.","volume":"221","author":"Xie","year":"2017","journal-title":"Acta Physiol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.freeradbiomed.2022.03.010","article-title":"Co-administration of hydrogen and metformin exerts cardioprotective effects by inhibiting pyroptosis and fibrosis in diabetic cardiomyopathy.","volume":"183","author":"Zou","year":"2022","journal-title":"Free Radic Biol Med."},{"key":"B100","doi-asserted-by":"publisher","first-page":"149","DOI":"10.4239\/wjd.v9.i9.149","article-title":"Effects of glucagon-like peptide 1 analogs in combination with insulin on myocardial infarct size in rats with type 2 diabetes mellitus.","volume":"9","author":"Zykov","year":"2018","journal-title":"World J Diabetes."},{"key":"B101","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1177\/1074248417729881","article-title":"Effect of ischemic postconditioning on myocardial function and infarct size following reperfusion injury in diabetic rats pretreated with vildagliptin.","volume":"23","author":"Bayrami","year":"2018","journal-title":"J Cardiovasc Pharmacol Ther."},{"key":"B102","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1093\/cvr\/cvv171","article-title":"Combination therapy with remote ischaemic conditioning and insulin or exenatide enhances infarct size limitation in pigs.","volume":"107","author":"Alburquerque-B\u00e9jar","year":"2015","journal-title":"Cardiovasc Res."},{"key":"B103","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.niox.2022.04.004","article-title":"Hydrogen sulfide potentiates the protective effects of nitrite against myocardial ischemia-reperfusion injury in type 2 diabetic rats.","volume":"124","author":"Jeddi","year":"2022","journal-title":"Nitric Oxide."},{"key":"B104","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1475-2840-11-4","article-title":"Hyperglycemia raises the threshold of levosimendan- but not milrinone-induced postconditioning in rat hearts.","volume":"11","author":"Matsumoto","year":"2012","journal-title":"Cardiovasc Diabetol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"4517","DOI":"10.3390\/ijms22094517","article-title":"Combination of cyclosporine A and levosimendan induces cardioprotection under acute hyperglycemia.","volume":"22","author":"Torregroza","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B106","doi-asserted-by":"publisher","first-page":"e002424","DOI":"10.1161\/CIRCHEARTFAILURE.115.002424","article-title":"Chronic co-administration of sepiapterin and l-citrulline ameliorates diabetic cardiomyopathy and myocardial ischemia\/reperfusion injury in obese type 2 diabetic mice.","volume":"9","author":"Baumgardt","year":"2016","journal-title":"Circ Heart Fail."},{"key":"B107","doi-asserted-by":"publisher","first-page":"e12698","DOI":"10.1111\/jpi.12698","article-title":"Melatonin attenuates diabetic cardiomyopathy and reduces myocardial vulnerability to ischemia-reperfusion injury by improving mitochondrial quality control: role of SIRT6.","volume":"70","author":"Yu","year":"2021","journal-title":"J Pineal Res."},{"key":"B108","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00424-012-1152-5","article-title":"Propofol improves recovery of the isolated working hypertrophic heart from ischaemia-reperfusion.","volume":"464","author":"King","year":"2012","journal-title":"Pflugers Arch."},{"key":"B109","doi-asserted-by":"publisher","first-page":"e0177315","DOI":"10.1371\/journal.pone.0177315","article-title":"Adenosine A1 receptor activation increases myocardial protein S-nitrosothiols and elicits protection from ischemia-reperfusion injury in male and female hearts.","volume":"12","author":"Shao","year":"2017","journal-title":"PLoS One."},{"key":"B110","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00395-009-0075-6","article-title":"Effects of a protocol of ischemic postconditioning and\/or captopril in hearts of normotensive and hypertensive rats.","volume":"105","author":"Penna","year":"2010","journal-title":"Basic Res Cardiol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00395-010-0143-y","article-title":"Ischemia\/reperfusion injury is increased and cardioprotection by a postconditioning protocol is lost as cardiac hypertrophy develops in nandrolone treated rats.","volume":"106","author":"Penna","year":"2011","journal-title":"Basic Res Cardiol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1016\/S0735-1097(98)00441-0","article-title":"Infarct size reduction by AT1-receptor blockade through a signal cascade of AT2-receptor activation, bradykinin and prostaglandins in pigs.","volume":"32","author":"Jalowy","year":"1998","journal-title":"J Am Coll Cardiol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1161\/01.CIR.90.3.1368","article-title":"Attenuation of myocardial stunning by the ACE inhibitor ramiprilat through a signal cascade of bradykinin and prostaglandins but not nitric oxide.","volume":"90","author":"Ehring","year":"1994","journal-title":"Circulation."},{"key":"B114","doi-asserted-by":"publisher","first-page":"679060","DOI":"10.3389\/fphar.2021.679060","article-title":"Increased endogenous activity of the renin-angiotensin system reduces infarct size in the rats with early angiotensin ii-dependent hypertension which survive the acute ischemia\/reperfusion injury.","volume":"12","author":"Huskov\u00e1","year":"2021","journal-title":"Front Pharmacol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1124\/pr.107.06002","article-title":"Interaction of cardiovascular risk factors with myocardial ischemia\/reperfusion injury, preconditioning, and postconditioning.","volume":"59","author":"Ferdinandy","year":"2007","journal-title":"Pharmacol Rev."},{"key":"B116","doi-asserted-by":"publisher","first-page":"500","DOI":"10.6061\/clinics\/2015(07)07","article-title":"Olmesartan restores the protective effect of remote ischemic perconditioning against myocardial ischemia\/reperfusion injury in spontaneously hypertensive rats.","volume":"70","author":"Lu","year":"2015","journal-title":"Clinics."},{"key":"B117","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1161\/CIRCRESAHA.115.308278","article-title":"Radiofrequency Renal Denervation Protects the Ischemic Heart via Inhibition of GRK2 and Increased Nitric Oxide Signaling.","volume":"119","author":"Polhemus","year":"2016","journal-title":"Circ Res."},{"key":"B118","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1016\/j.jacc.2017.08.056","article-title":"Renal sympathetic denervation protects the failing heart via inhibition of neprilysin activity in the kidney.","volume":"70","author":"Polhemus","year":"2017","journal-title":"J Am Coll Cardiol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00395-019-0718-1","article-title":"Repeated cell transplantation and adjunct renal denervation in ischemic heart failure: exploring modalities for improving cell therapy efficacy.","volume":"114","author":"Polhemus","year":"2019","journal-title":"Basic Res Cardiol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00395-020-0776-4","article-title":"Renal denervation restrains the inflammatory response in myocardial ischemia-reperfusion injury.","volume":"115","author":"Sun","year":"2020","journal-title":"Basic Res Cardiol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1111\/bph.13704","article-title":"Effect of hypercholesterolaemia on myocardial function, ischaemia-reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning.","volume":"174","author":"Andreadou","year":"2017","journal-title":"Br J Pharmacol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1161\/CIRCULATIONAHA.108.842724","article-title":"Effect of hypercholesterolemia on myocardial necrosis and apoptosis in the setting of ischemia-reperfusion.","volume":"120","author":"Osipov","year":"2009","journal-title":"Circulation."},{"key":"B123","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.3390\/ijms22052519","article-title":"Pharmacological conditioning of the heart: an update on experimental developments and clinical implications.","volume":"22","author":"Roth","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B124","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1097\/SHK.0000000000000737","article-title":"Hypercholesterolemia abrogates remote ischemic preconditioning-induced cardioprotection: role of reperfusion injury salvage kinase signals.","volume":"47","author":"Ma","year":"2017","journal-title":"Shock."},{"key":"B125","doi-asserted-by":"publisher","first-page":"H1907","DOI":"10.1152\/ajpheart.01242.2010","article-title":"Cholesterol diet leads to attenuation of ischemic preconditioning-induced cardiac protection: the role of connexin 43.","volume":"300","author":"G\u00f6rbe","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00395-004-0485-4","article-title":"Hypercholesterolemia blunts NO donor-induced late preconditioning against myocardial infarction in conscious rabbits.","volume":"99","author":"Tang","year":"2004","journal-title":"Basic Res Cardiol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s11010-012-1386-8","article-title":"Pharmacological inhibition of GSK-3\u03b2 produces late phase of cardioprotection in hyperlipidemic rat: possible involvement of HSP 72.","volume":"369","author":"Yadav","year":"2012","journal-title":"Mol Cell Biochem."},{"key":"B128","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1093\/abbs\/gmp063","article-title":"Hyperlipidemia does not prevent the cardioprotection by postconditioning against myocardial ischemia\/reperfusion injury and the involvement of hypoxia inducible factor-1alpha upregulation.","volume":"41","author":"Zhao","year":"2009","journal-title":"Acta Biochim Biophys Sin."},{"key":"B129","doi-asserted-by":"publisher","first-page":"H405","DOI":"10.1152\/ajpheart.00257.2013","article-title":"Cholesterol-enriched diet inhibits cardioprotection by ATP-sensitive K+ channel activators cromakalim and diazoxide.","volume":"306","author":"Csonka","year":"2014","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.numecd.2009.06.010","article-title":"Cyclosporine A administered during reperfusion fails to restore cardioprotection in prediabetic Zucker obese rats in vivo.","volume":"20","author":"Huhn","year":"2010","journal-title":"Nutr Metab Cardiovasc Dis."},{"key":"B131","first-page":"446","article-title":"Blocking the mitochondrial permeability transition pore with cyclosporine-A can restore cardioprotection of ischemic postconditioning in hypercholesterolemic rat heart.","volume":"19","author":"Wu","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"B132","doi-asserted-by":"publisher","first-page":"6990","DOI":"10.3390\/ijms21196990","article-title":"Cardioprotective effect of novel matrix metalloproteinase inhibitors.","volume":"21","author":"G\u00f6m\u00f6ri","year":"2020","journal-title":"Int J Mol Sci."},{"key":"B133","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00395-013-0331-7","article-title":"Matrix metalloproteinase inhibition protects CyPD knockout mice independently of RISK\/mPTP signalling: a parallel pathway to protection.","volume":"108","author":"Bell","year":"2013","journal-title":"Basic Res Cardiol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/SHK.0000000000001296","article-title":"Pharmacological inhibition of PTEN restores remote ischemic postconditioning cardioprotection in hypercholesterolemic mice: potential role of PTEN\/AKT\/GSK3\u03b2 SIGNALS.","volume":"52","author":"Hong","year":"2019","journal-title":"Shock."},{"key":"B135","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1093\/cvr\/cvz061","article-title":"Investigating and re-evaluating the role of glycogen synthase kinase 3 beta kinase as a molecular target for cardioprotection by using novel pharmacological inhibitors.","volume":"115","author":"Nikolaou","year":"2019","journal-title":"Cardiovasc Res."},{"key":"B136","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1093\/cvr\/cvs121","article-title":"Short-term statin administration in hypercholesterolaemic rabbits resistant to postconditioning: effects on infarct size, endothelial nitric oxide synthase, and nitro-oxidative stress.","volume":"94","author":"Andreadou","year":"2012","journal-title":"Cardiovasc Res."},{"key":"B137","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/cvr\/cvp033","article-title":"Loss of cardioprotection with ageing.","volume":"83","author":"Boengler","year":"2009","journal-title":"Cardiovasc Res."},{"key":"B138","doi-asserted-by":"publisher","first-page":"H1727","DOI":"10.1152\/ajpheart.00054.2013","article-title":"Aging attenuates the protective effect of ischemic preconditioning against endothelial ischemia-reperfusion injury in humans.","volume":"304","author":"van den Munckhof","year":"2013","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1161\/CIRCULATIONAHA.108.805242","article-title":"Cardioprotection: nitric oxide, protein kinases, and mitochondria.","volume":"118","author":"Heusch","year":"2008","journal-title":"Circulation."},{"key":"B140","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.ijcard.2016.06.200","article-title":"Involvement of exogenous H2S in recovery of cardioprotection from ischemic post-conditioning via increase of autophagy in the aged hearts.","volume":"220","author":"Chen","year":"2016","journal-title":"Int J Cardiol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/1440-1681.13616","article-title":"Pretreatment with nicotinamide mononucleotide increases the effect of ischaemic postconditioning on cardioprotection and mitochondrial function following ex vivo myocardial reperfusion injury in aged rats.","volume":"49","author":"Rajabi","year":"2022","journal-title":"Clin Exp Pharmacol Physiol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.exger.2004.10.005","article-title":"Tandem action of exercise training and food restriction completely preserves ischemic preconditioning in the aging heart.","volume":"40","author":"Abete","year":"2005","journal-title":"Exp Gerontol."},{"key":"B143","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1093\/cvr\/cvaa132","article-title":"Cardiomyocyte ageing and cardioprotection: consensus document from the ESC working groups cell biology of the heart and myocardial function.","volume":"116","author":"Ruiz-Meana","year":"2020","journal-title":"Cardiovasc Res."},{"key":"B144","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1177\/1074248419882002","article-title":"Melatonin and nicotinamide mononucleotide attenuate myocardial ischemia\/reperfusion injury via modulation of mitochondrial function and hemodynamic parameters in aged rats.","volume":"25","author":"Hosseini","year":"2020","journal-title":"J Cardiovasc Pharmacol Ther."},{"key":"B145","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/j.1600-079X.2010.00758.x","article-title":"Increased susceptibility to Ca(2+)-induced permeability transition and to cytochrome c release in rat heart mitochondria with aging: effect of melatonin.","volume":"48","author":"Petrosillo","year":"2010","journal-title":"J Pineal Res."},{"key":"B146","doi-asserted-by":"publisher","first-page":"e13096","DOI":"10.1111\/acel.13096","article-title":"Metformin mediates cardioprotection against aging-induced ischemic necroptosis.","volume":"19","author":"Li","year":"2020","journal-title":"Aging cell."},{"key":"B147","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.healun.2009.10.011","article-title":"Amelioration of rat cardiac cold ischemia\/reperfusion injury with inhaled hydrogen or carbon monoxide, or both.","volume":"29","author":"Nakao","year":"2010","journal-title":"J Heart Lung Transplant."},{"key":"B148","doi-asserted-by":"publisher","first-page":"770421","DOI":"10.3389\/fcvm.2021.770421","article-title":"Potential therapies to protect the aging heart against ischemia\/reperfusion injury.","volume":"8","author":"D\u00edaz-Vesga","year":"2021","journal-title":"Front Cardiovasc Med."},{"key":"B149","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1161\/CIRCULATIONAHA.116.022829","article-title":"Cardioprotection: the disconnect between bench and bedside.","volume":"134","author":"Rossello","year":"2016","journal-title":"Circulation."},{"key":"B150","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1093\/eurheartj\/ehw145","article-title":"Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations.","volume":"38","author":"Hausenloy","year":"2017","journal-title":"Eur Heart J."},{"key":"B151","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00395-018-0696-8","article-title":"Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection.","volume":"113","author":"B\u00f8tker","year":"2018","journal-title":"Basic Res Cardiol."},{"key":"B152","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jacc.2019.05.024","article-title":"Cardiac MRI endpoints in myocardial infarction experimental and clinical trials: JACC scientific expert panel.","volume":"74","author":"Ibanez","year":"2019","journal-title":"J Am Coll Cardiol."},{"key":"B153","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s00395-021-00842-2","article-title":"Effect of COMBinAtion therapy with remote ischemic conditioning and exenatide on the Myocardial Infarct size: a two-by-two factorial randomized trial (COMBAT-MI).","volume":"116","author":"Garc\u00eda Del Blanco","year":"2021","journal-title":"Basic Res Cardiol."},{"key":"B154","doi-asserted-by":"publisher","first-page":"H812","DOI":"10.1152\/ajpheart.00335.2017","article-title":"Guidelines for experimental models of myocardial ischemia and infarction.","volume":"314","author":"Lindsey","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"B155","doi-asserted-by":"publisher","first-page":"H1056","DOI":"10.1152\/ajpheart.00459.2021","article-title":"Guidelines for in vivo mouse models of myocardial infarction.","volume":"321","author":"Lindsey","year":"2021","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.actbio.2019.05.064","article-title":"In vitro aged, hiPSC-origin engineered heart tissue models with age-dependent functional deterioration to study myocardial infarction.","volume":"94","author":"Acun","year":"2019","journal-title":"Acta biomater."},{"key":"B157","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1093\/eurheartj\/ehz779","article-title":"Living myocardial slices: a novel multicellular model for cardiac translational research.","volume":"41","author":"Perbellini","year":"2020","journal-title":"Eur Heart J."},{"key":"B158","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1038\/s41467-019-10175-3","article-title":"Biomimetic electromechanical stimulation to maintain adult myocardial slices in vitro.","volume":"10","author":"Watson","year":"2019","journal-title":"Nat Commun."},{"key":"B159","doi-asserted-by":"publisher","first-page":"e009540","DOI":"10.1161\/JAHA.118.009540","article-title":"Mitochondrial and contractile function of human right atrial tissue in response to remote ischemic conditioning.","volume":"7","author":"Kleinbongard","year":"2018","journal-title":"J Am Heart Assoc."},{"key":"B160","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1161\/CIRCULATIONAHA.120.051923","article-title":"Mitochondrial telomerase reverse transcriptase protects from myocardial ischemia\/reperfusion injury by improving complex i composition and function.","volume":"144","author":"Ale-Agha","year":"2021","journal-title":"Circulation."},{"key":"B161","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.yjmcc.2017.11.011","article-title":"A protocol to study ex vivo mouse working heart at human-like heart rate.","volume":"114","author":"Feng","year":"2018","journal-title":"J Mol Cell Cardiol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s00395-020-00830-y","article-title":"The importance of clinically relevant background therapy in cardioprotective studies.","volume":"115","author":"He","year":"2020","journal-title":"Basic Res Cardiol."},{"key":"B163","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1159\/000441216","article-title":"Confounders of cardioprotection by remote ischemic preconditioning in patients undergoing coronary artery bypass grafting.","volume":"133","author":"Kleinbongard","year":"2016","journal-title":"Cardiology."},{"key":"B164","doi-asserted-by":"publisher","first-page":"341s12","DOI":"10.1126\/scitranslmed.aaf5027","article-title":"What does research reproducibility mean?","volume":"8","author":"Goodman","year":"2016","journal-title":"Sci Transl Med."},{"key":"B165","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1023\/A:1007850527878","article-title":"Adenosine A1 agonist at reperfusion trial (AART): results of a three-center, blinded, randomized, controlled experimental infarct study.","volume":"14","author":"Baxter","year":"2000","journal-title":"Cardiovasc Drugs Ther."},{"key":"B166","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/s41551-018-0322-y","article-title":"Design preclinical studies for reproducibility.","volume":"2","author":"Kim","year":"2018","journal-title":"Nat Biomed Eng."},{"key":"B167","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1177\/1074248411414155","article-title":"Development of an NIH consortium for preclinicAl AssESsment of CARdioprotective therapies (CAESAR): a paradigm shift in studies of infarct size limitation.","volume":"16","author":"Lefer","year":"2011","journal-title":"J Cardiovasc Pharmacol Ther."},{"key":"B168","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1161\/CIRCRESAHA.116.305462","article-title":"The NHLBI-sponsored Consortium for preclinicAl assESsment of cARdioprotective therapies (CAESAR): a new paradigm for rigorous, accurate, and reproducible evaluation of putative infarct-sparing interventions in mice, rabbits, and pigs.","volume":"116","author":"Jones","year":"2015","journal-title":"Circ Res."},{"key":"B169","doi-asserted-by":"publisher","first-page":"20290","DOI":"10.1038\/s41598-019-56613-6","article-title":"CIBER-CLAP (CIBERCV Cardioprotection Large Animal Platform): a multicenter preclinical network for testing reproducibility in cardiovascular interventions.","volume":"9","author":"Rossello","year":"2019","journal-title":"Sci Rep."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.967115\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T05:43:14Z","timestamp":1661146994000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.967115\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,22]]},"references-count":169,"alternative-id":["10.3389\/fcvm.2022.967115"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.967115","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,22]]},"article-number":"967115"}}